0001944596-22-000001.txt : 20220908 0001944596-22-000001.hdr.sgml : 20220908 20220908152702 ACCESSION NUMBER: 0001944596-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220908 DATE AS OF CHANGE: 20220908 EFFECTIVENESS DATE: 20220908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Noumea Biosciences Inc. CENTRAL INDEX KEY: 0001944596 IRS NUMBER: 883639316 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-458351 FILM NUMBER: 221233669 BUSINESS ADDRESS: STREET 1: 79 DRESSER ST CITY: BOSTON STATE: MA ZIP: 02127 BUSINESS PHONE: 6178039058 MAIL ADDRESS: STREET 1: 79 DRESSER ST CITY: BOSTON STATE: MA ZIP: 02127 D 1 primary_doc.xml X0708 D LIVE 0001944596 Noumea Biosciences Inc. 79 DRESSER ST BOSTON MA MASSACHUSETTS 02127 6178039058 DELAWARE None None Corporation true 2022 Matthew Blum 79 Dresser St Boston MA MASSACHUSETTS 02127 Executive Officer Director Biotechnology Decline to Disclose 06b false 2022-09-07 false true true SAFE (Simple Agreement for Future Equity) false 300000 300000 300000 0 false 1 0 0 85000 true Proceeds will primarily be used to fund research & development, capital expenditures, and operating expenses which may include salary payments to executives. false Noumea Biosciences Inc. Matthew Blum Matthew Blum CEO 2022-09-08